These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 9469432

  • 21. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
    Gorelik E.
    Cancer Res; 1987 Feb 01; 47(3):809-15. PubMed ID: 3802083
    [Abstract] [Full Text] [Related]

  • 22. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
    Wu B, Shen RN, Wang WX, Broxmeyer HE, Lu L.
    Stem Cells; 1993 Sep 01; 11(5):412-21. PubMed ID: 8241952
    [Abstract] [Full Text] [Related]

  • 23. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N, Tokura Y, Takigawa M, Egawa K.
    J Immunol; 1999 Jul 01; 163(1):242-9. PubMed ID: 10384122
    [Abstract] [Full Text] [Related]

  • 24. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.
    Weber SM, Qi C, Neal Z, Sondel P, Mahvi DM.
    J Surg Res; 2004 Dec 01; 122(2):210-7. PubMed ID: 15555620
    [Abstract] [Full Text] [Related]

  • 25. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T, Takehara T, Kanto T, Miyagi T, Kuzushita N, Sugimoto Y, Jinushi M, Kasahara A, Sasaki Y, Hori M, Hayashi N.
    Cancer Res; 2001 Oct 15; 61(20):7563-7. PubMed ID: 11606395
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer.
    Hunter CA, Timans J, Pisacane P, Menon S, Cai G, Walker W, Aste-Amezaga M, Chizzonite R, Bazan JF, Kastelein RA.
    Eur J Immunol; 1997 Nov 15; 27(11):2787-92. PubMed ID: 9394800
    [Abstract] [Full Text] [Related]

  • 27. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18.
    Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Ikegami H, Kurimoto M.
    Anticancer Res; 1998 Nov 15; 18(6A):4267-74. PubMed ID: 9891477
    [Abstract] [Full Text] [Related]

  • 28. Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.
    Jin GH, Hirano T, Murakami M.
    Int Immunol; 2008 Jun 15; 20(6):783-9. PubMed ID: 18448458
    [Abstract] [Full Text] [Related]

  • 29. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.
    Markovic SN, Murasko DM.
    Cancer Res; 1991 Feb 15; 51(4):1124-8. PubMed ID: 1705166
    [Abstract] [Full Text] [Related]

  • 30. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL, Janssen K, Hao Z, Sondel PM, Yang NS.
    Cancer Gene Ther; 2000 Jun 15; 7(6):826-38. PubMed ID: 10880012
    [Abstract] [Full Text] [Related]

  • 31. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.
    Tahara H, Zitvogel L, Storkus WJ, Zeh HJ, McKinney TG, Schreiber RD, Gubler U, Robbins PD, Lotze MT.
    J Immunol; 1995 Jun 15; 154(12):6466-74. PubMed ID: 7759882
    [Abstract] [Full Text] [Related]

  • 32. B7-1 and interleukin 12 synergistically induce effective antitumor immunity.
    Coughlin CM, Wysocka M, Kurzawa HL, Lee WM, Trinchieri G, Eck SL.
    Cancer Res; 1995 Nov 01; 55(21):4980-7. PubMed ID: 7585539
    [Abstract] [Full Text] [Related]

  • 33. Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas.
    Fogler WE, Volker K, Watanabe M, Wigginton JM, Roessler P, Brunda MJ, Ortaldo JR, Wiltrout RH.
    J Immunol; 1998 Dec 01; 161(11):6014-21. PubMed ID: 9834083
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG, Younes E, Visscher D, Hamzavi F, Kim S, Lam JS, Montecillo EJ, Ali E, Pontes JE, Puri RK, Haas GP.
    Clin Cancer Res; 1997 Oct 01; 3(10):1799-806. PubMed ID: 9815566
    [Abstract] [Full Text] [Related]

  • 35. Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvant.
    Sturmhoefel K, Lee K, Gray GS, Thomas J, Zollner R, O'Toole M, Swiniarski H, Dorner A, Wolf SF.
    Cancer Res; 1999 Oct 01; 59(19):4964-72. PubMed ID: 10519410
    [Abstract] [Full Text] [Related]

  • 36. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H, Seki S, Habu Y, Ohkawa T, Takeshita S, Hiraide H, Sekine I.
    Hepatology; 1999 Aug 01; 30(2):430-6. PubMed ID: 10421651
    [Abstract] [Full Text] [Related]

  • 37. Subtherapeutic doses of interleukin-15 augment the antitumor effect of interleukin-12 in a B16F10 melanoma model in mice.
    Lasek W, Golab J, Maśliński W, Switaj T, Bałkowiec EZ, Stokłosa T, Giermasz A, Malejczyk M, Jakóbisiak M.
    Eur Cytokine Netw; 1999 Sep 01; 10(3):345-56. PubMed ID: 10477391
    [Abstract] [Full Text] [Related]

  • 38. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
    Oniki S, Nagai H, Horikawa T, Furukawa J, Belladonna ML, Yoshimoto T, Hara I, Nishigori C.
    Cancer Res; 2006 Jun 15; 66(12):6395-404. PubMed ID: 16778218
    [Abstract] [Full Text] [Related]

  • 39. Differential requirement of IFN consensus sequence binding protein for the production of IL-12 and induction of Th1-type cells in response to IFN-gamma.
    Wu CY, Maeda H, Contursi C, Ozato K, Seder RA.
    J Immunol; 1999 Jan 15; 162(2):807-12. PubMed ID: 9916702
    [Abstract] [Full Text] [Related]

  • 40. Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells.
    Sabel MS, Arora A, Su G, Mathiowitz E, Reineke JJ, Chang AE.
    Surgery; 2007 Nov 15; 142(5):749-60. PubMed ID: 17981196
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.